The Sunrise Podcast: Avoiding the Pain Points of Getting MedTech to Market, with Adam Jacobs

 

Getting a medical product to market is no simple task. From conception, to development, to marketing to appeal to audiences worldwide, every step has its speed bumps, and like a speed bump, and put in place for good measure. Quality control for feasibility and engineering tests both play a part in making sure that the product is functional, viable, and in many cases, FDA approved.

On today’s episode of The Sunrise Podcast, Adam Jacobs, Chief Technology Officer at Sunrise Labs, reeducates on how products are submitted and certified by the FDA and what kind of things need to be done during product development, including ISO 13485 certification for medical devices.

It’s a long and necessary process, especially when the product needs to be manufactured so that it’s reliable and economically sound for the consumer, but also profitable, and that’s where complications often come in. Many companies may work on a single product for long periods of time and end up not getting exposure, and everyone wants to “get to profitability as quickly as they can,” according to Jacobs.

“We probably have 20 or so projects at any given time, and as CTO I’m lucky and get to be exposed to most of them,” Jacobs said, which also means that he sees the products that weren’t put together well. “Getting a mature vision of what you want it to be is often one of the best things that you can do,” because otherwise medtech companies may have to change their products or production process downstream, an expensive and time-consuming mistake.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @HealthMKSL
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Robotics
Episode 3 Promo: Inside Vecna Robotics’ Mission to Build Safer Automated Warehouses
May 9, 2025

The third episode of Robot vs. Wild takes a close look at one of the most critical success factors in automation: robot safety. Featuring Michael Bearman, Chief Legal & Safety Officer, and Josh Kivenko, Chief Marketing Officer at Vecna Robotics, this episode explores why safety in automation isn’t just about the robots—it’s about people, processes,…

Read More
Vecna Robotics
Episode 4 Promo: How Vecna Robotics Connects Tech and Strategy for Smarter Automation
May 9, 2025

Episode four of Robot vs. Wild features a conversation between Zachary Dydek, Chief Technology Officer at Vecna Robotics, and Josh Kivenko, the company’s Chief Marketing Officer. The episode explores the advanced technologies behind Vecna’s automation solutions and how engineering and marketing align to deliver scalable, human-centered innovation. Topics include real-time orchestration, autonomous systems, and how…

Read More
automation
Episode 5 Promo: There Are No Bad Robots, Only Bad Owners
May 9, 2025

What really makes or breaks a robotics deployment? Spoiler: it’s not the robot. In the fifth episode of Robot vs. Wild, Vecna Robotics’ Chief Marketing Officer Josh Kivenko and Customer Success Manager Ty LaFramboise reveal why successful automation is less about machines—and more about mindset. From aligning corporate goals with floor-level operations, to helping teams adjust to new…

Read More
Jerry Wagner discusses Market Volatility
The DisruptED World of Financial Services with Industry Titan Jerry Wagner
May 9, 2025

Because this is an era now defined by economic whiplash, algorithmic finance, and global uncertainty, the investment world is increasingly more volatile than before. As inflationary pressures, geopolitical tensions, and trade policies create even further chaos into markets, the stakes for both advisors and investors have heightened. According to data on the Cboe Volatility…

Read More